Abnormalities of Retinal Metabolism in Diabetes and Experimental Galactosemia: VII. Effect of Long-Term Administration of Antioxidants on the Development of Retinopathy

Diabetes

Volumn 50, Issue 8, 2001, Pages 1938-1942

  Kowluru, Renu A ^a   Tang, Jie ^b   Kern, Timothy S ^b  

^a WAYNE STATE UNIVERSITY   (United States)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

6-HYDROXY-2,5,7,8-TETRAMETHYLCHROMAN-2-CARBOXYLIC ACID; ACETYLCYSTEINE; ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; BETA CAROTENE; CHROMAN DERIVATIVE; SELENIUM; TROLOX C;

ANIMAL; ARTICLE; DIABETIC RETINOPATHY; DIET; DIET SUPPLEMENTATION; DRUG EFFECT; EXPERIMENTAL DIABETES MELLITUS; GALACTOSEMIA; MALE; METABOLISM; PATHOPHYSIOLOGY; PERICYTE; RAT; RETINA; RETINA DISEASE; SPRAGUE DAWLEY RAT;

ACETYLCYSTEINE; ANIMALS; ANTIOXIDANTS; ASCORBIC ACID; BETA CAROTENE; CHROMANS; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC RETINOPATHY; DIET; DIETARY SUPPLEMENTS; GALACTOSEMIAS; MALE; PERICYTES; RATS; RATS, SPRAGUE-DAWLEY; RETINA; RETINAL DISEASES; SELENIUM; VITAMIN E;

EID: 0035434119     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.50.8.1938     Document Type: Article

References (45)

1. Engerman RL, Kern TS: Experimental galactosemia produces diabetic-like retinopathy. Diabetes 33:97-100, 1984
2. Robison WG Jr, Tillis TN, Laver N, Kinoshita JH: Diabetes-related histopathologies of the rat retina prevented with an aldose reductase inhibitor. Exp Eye Res 50:355-366, 1990
3. Kern TS, Engerman RL: Galactose-induced retinal microangiopathy in rats. Invest Ophthalmol Vis Sci 36:490-496, 1995
4. Kern TS, Engerman RL: A mouse model of diabetic retinopathy. Arch Ophthalmol 114:986-990, 1996
5. Stitt AW, Li YM, Gardiner TA, Bucala R, Archer DB, Vlassara H: Advanced glycation end products (AGEs) co-localize with AGE receptors in the retinal vasculature of diabetic and of AGE-infused rats. Am J Pathol 150:523-531, 1997
6. Xia P, Inoguchi T, Kern TS, Engerman RL, Oates PJ, King GL: Characterization of the mechanism for the chronic activation of DAG-PKC pathway in diabetes and hypergalactosemia. Diabetes 43:1122-1129, 1994
7. Kowluru RA, Jirousek MR, Stramm LE, Farid NA, Engerman RL, Kern TS: Abnormalities of retinal nietabolism in diabetes or experimental galactosemia. V. Relationship between protein kinase C and ATPases. Diabetes 47:464-469, 1998
8. Armstrong D, Abdella N, Salman A, Miller N, Rahman EA, Bojancyzk M: Relationship of lipid peroxides to diabetic complications. J Diabetes Complications 6:116-122, 1992
9. Kowluru RA, Kern TS, Engerman RL, Armstrong D: Abnormalities of retinal metabolism in diabetes or experimental galactosemia. III. Effects of antioxidants. Diabetes 45:1233-1237, 1996
10. Kador PF, Akagi Y, Takahashi Y, Ikebe H, Wyman M, Kinoshita JH: Prevention of retinal vessel changes associated with diabetic retinopathy in galactose-fed dogs by aldose reductase inhibitors. Arch Ophthalmol 108:1301-1309, 1990
11. Aiello LP, Pu X, Zhen ZY, Park DJ, Newsome WP, King GL: Vascular endothelial growth factor (VEGF) activation of phospholipase C-gamma, P13-kinase & PKC pathways and their effects on endothelial cell proliferation. Invest Ophthatmol Vis Sci 37:S204, 1996
12. Baynes JW: Role of oxidative stress in development of complications in diabetes. Diabetes 40:405-412, 1991
13. Kowluru RA. Kern TS, Engerman RL: Abnormalities of retinal metabolism in diabetes or experimental galactosemia. IV. Antioxidant defense system. Free Radic Biol Med 22:587-592, 1997
14. Kowluru RA, Engerman RL, Kern TS: Diabetes-induced metabolic abnormalities in myocardium: effect of antioxidant therapy. Free Radic Res 32:67-74, 2000
15. Grant MB, Ellis EA, Wachowski MB, Murray FT: Free radical derived oxidant localization in retinas of BBZ/WOR diabetic rats (Abstract). Diabetes 45 (Suppl. 2):192, 1996
16. Kowluru R, Kern TS, Engerman RL: Abnormalities of retinal metabolism in diabetes or galactosemia II. Comparison of gamma-glutamyl transpeptidase in retina and cerebral cortex, and effects of antioxidant therapy. Curr Eye Res 13:891-896, 1994
17. Mayer-Davis EJ, Bell RA, Reboussin BA, Rushing J, Marshall JA, Hamman RF: Antioxidant nutrient intake and diabetic retinopathy: the San Luis Valley Diabetes Study. Ophthalmology 105:2264-2270, 1998
18. Hammes HP, Bartmann A, Engel L, Wulfroth P: Antioxidant treatment of experimental diabetic retinopathy in rats with nicanartine. Diabetologia 40:629-634, 1997
19. Ansari NH, Zhang W, Fulep E, Mansour A: Prevention of pericyte loss by Trolox in diabetic rat retina. J Toxicol Environ Health 24:467-475, 1998
20. Kowluru RA, Engerman RL, Kern TS: Abnormalities of retinal metabolism in diabetes or experimental galactosemia VI. Comparison of retinal and cerebral cortex metabolism, and effects of antioxidant therapy. Free Radic Biol Med 26:371-378, 1998
21. Ishii H, Koya D, King GL: Protein kinase C activation and its role in the development of vascular complications in diabetes mellitus. J Mol Med 76:21-31, 1998
22. Kowluru RA, Engerman RL, Case GL, Kern TS: Retinal glutamate in diabetes and effect of antioxidants. Neurochem Int 38:385-391, 2001
23. Bradford MM: A rapid and sensitive method for the quantitation of microgram quantities of protein. Anal Biochem 72:248-258, 1974
24. Engerman RL, Kern TS: Retinopathy in animal models of diabetes. Diabetes Metab Rev 11:109-120, 1995
25. Kern TS, Tang J, Mizutani M, Kowluru RA, Nagraj RH, Romeo G, Podesta F, Lorenzi M: Response of capillary cell death to aminoguanidine predicts the development of retinopathy: comparison of diabetes and galactosemia. Invest Ophthalmol Vis Sci 41:3972-3978, 2000
26. Siperstein M, Under R, Madison L: Studies of muscle capillary basement membrane in normal subjects, diabetic, and prediabetic patients. J Clin Invest 47:1973-1999, 1968
27. Tesfamariam B, Cohen RA: Free radicals mediate endothelial dysfunction caused by elevated glucose. Am J Physiol 263:H321-H326, 1992
28. Kern TS, Kowluru R, Engerman RL: Abnormalities of retinal metabolism in diabetes or galactosemia: ATPases and glutathione. Invest Ophthalmol Vis Sci 35:2962-2967, 1994
29. Wohaieb SA, Godin DV: Alterations in free radical tissue-defense mechanisms in streptozotocin-induced diabetes. Diabetes 36:1014-1018, 1987
30. Ellis EA, Grant MB, Murray FT, Guberski DL, Kubilis PS, Lutty GA: Increased NADH oxidase activity in the retina of BBZ/W or diabetic rat. Free Radic Biol Med 24:111-120, 1998
31. Li W, Yanoff M, Jian B, He Z: Altered mRNA levels of antioxidant enzymes in pre-apoptotic pericytes from human diabetic retinas. Cell Mol Biol 45:59-66, 1999
32. Knudsen CA, Tappel AL, North JA: Multiple antioxidants protect against heme protein and lipid oxidation in kidney tissue. Free Radic Biol Med 20:165-173, 1996
33. Pryor WA: Vitamin E and heart disease: basic science to clinical intervention trials. Free Radic Biol Med 28:141-164, 2000
34. Brownlee M, Vlassara H, Kooney A, Ulrich P, Cerami A: Aminoguanidine prevents diabetes-induced arterial wall protein cross linking. Science 232:1629-1632, 1986
35. Picard S, Parthasarathy S, Fruebis J, Wiztum JL: Aminoguanidine inhibits oxidative modification of low-density lipoprotein and the subsequent increase in uptake by macrophage scavenger receptors. Proc Natl Acad Sci U S A 89:6876-6880, 1992
36. Tilton RG, Chang K, Hasan KS, Smith SR, Petrash JM, Misko TP, Moore WM, Currie MG, Corbett JA, McDaniel ML: Prevention of diabetic vascular dysfunction by guanidines: inhibition of nitric oxide synthase versus advanced glycation end-product formation. Diabetes 42:221-232, 1993
37. Kowluru RA, Engerman EL, Kern TS: Abnormalities of retinal metabolism in diabetes or experimental galactosemia VIII. Prevention by aminoguanidine. Curr Eye Res 21:814-819, 2000
38. Cotter MA, Love A, Watt MJ, Cameron ME, Dines KC: Effects of natural free radical scavengers on peripheral nerve and neurovascular function in diabetic rats. Diabetologia 38:1285-1294, 1995
39. Koya D, Lee IK, Ishii H, Kanoh H, King GL: Prevention of glomerular dysfunction in diabetic rats by treatment with d-alpha tocopherol. J Am Soc Nephrol 8:426-435, 1997
40. Palumbo EJ, Sweatt JD, Chen SJ, Klann E: Oxidation-induced persistent activation of protein kinase C in hippocampal homogenates. Biochem Biophys Res Commun 187:1438-1445, 1992
41. Stauble B, Boscoboinik D, Tasinato A, Azzi A: Modulation of activator protein-1 (AP-1) transcription factor and protein kinase C by hydrogen peroxide and D-a-tocopherol in vascular smooth muscles. Eur J Biochem 226:393-402, 1994
42. Ha H, Yoon SJ, Kim KH: High glucose can induce lipid peroxidation in the isolated rat giomeruli. Kidney Int 46:1620-1626, 1994
43. Kowluru RA, Engerman RL, Kern TS: Oxidative stress and protein kinase C are inter-related in retinas of diabetic rats and galactose-fed rats (Abstract). Diabetes 46 (Suppl. 1):9A, 1997
44. Schreck R, Rieber P, Baeuerle PA: Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-kappa B transcription factor and HIV-1. EMBO J 10:2247-2258, 1991
45. Schrammel A, Koesling D, Schmidt K, Mayer B: Inhibition of purified soluble guanylyl cyclase by L-ascorbic acid. Cardiovasc Res 47:602-608, 2000